HGH 20 IU

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

HGH 191AA is recombinant human growth hormone (somatropin) — a 191-amino-acid protein identical to the growth hormone made by the pituitary gland[1][5]. Somatropin is FDA-approved for genuine medical indications such as growth-hormone deficiency, but use for anti-aging, bodybuilding or body-composition is off-label and not approved for those purposes. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks — presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 10 IU (3.33 mg) vial → ~1.11 mg/mL (~1,111 mcg/mL), a practical dilution for accurate dosing.
150–500 mcg daily in conservative replacement protocols, up to 1000–2000 mcg in advanced research; clinical GH-deficiency dosing is individualized to IGF-1.
At ~1.11 mg/mL, 1 unit ≈ 11.1 mcg on a U-100 syringe (1 unit = 0.01 mL). Roughly 1 mg somatropin ≈ 3 IU.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Extended 12-Week Protocol (Optional)

Week	Daily Dose (mcg)	Volume (U-100 units / mL)
Week 9	1000 mcg (1× daily)	90 units (0.90 mL)
Week 10	1100 mcg (1× daily)	99 units (0.99 mL)
Week 11	1200 mcg (1× daily)	108 units (1.08 mL)
Week 12	1300 mcg (1× daily)	117 units (1.17 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 10 IU (3.33 mg) vial → final concentration ~1.11 mg/mL (~1,111 mcg/mL).
Typical daily range: begin near 200 mcg and titrate by about 100 mcg per week; conservative replacement protocols use 150–500 mcg daily, advanced research up to 1000–2000 mcg daily.
Easy measuring: At ~1.11 mg/mL, 1 unit ≈ 11.1 mcg on a U-100 syringe (1 unit = 0.01 mL). Units = daily dose (mcg) ÷ 11.1.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection once daily, preferably at bedtime to mimic the body’s natural overnight GH pulse[2]. Rotate sites to avoid lipoatrophy[3]. This 8-week schedule escalates by ~100 mcg weekly. These figures come from reference protocols, not from approved human dosing.
Note: The 12-week extension reaches higher daily doses (1000–1300 mcg) explored in performance and metabolic research. These produce more pronounced effects but raise the chance of side effects such as insulin resistance, fluid retention and joint discomfort, and call for closer monitoring. Because a U-100 syringe holds only 100 units (1.0 mL), any daily dose above ~1000 mcg (~90 units) — e.g. Weeks 11–12 — must be split into two injections or drawn from a more concentrated reconstitution.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake, to preserve the protein structure.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution keeps even small starting doses at 18 units or more, where U-100 syringe markings are easiest to read. Avoid freezing the reconstituted solution, since freeze–thaw can denature the protein.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course of once-daily injections with gradual titration.

Each 10 IU (3.33 mg) vial covers part of a week as doses rise across the titration; plan extra for the higher weeks.
8 weeks: ~10 vials
12 weeks: ~19 vials
16 weeks: ~32 vials
Per injection: 1 syringe (1/day)
8 weeks: ~56 syringes
12 weeks: ~84 syringes
16 weeks: ~112 syringes
Use ~3.0 mL per vial for reconstitution.
8 weeks (10 vials): 30 mL → 3 bottles
12 weeks (19 vials): 57 mL → 6 bottles
16 weeks (32 vials): 96 mL → 10 bottles
One for the vial stopper + one for the injection site each day.
Per injection: 2 swabs
8 weeks: ~112 swabs → 2 boxes
16 weeks: ~224 swabs → 3 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

▪Goal: Support lean-mass gains, reductions in adipose tissue and improved metabolic function by raising IGF-1; clinically, somatropin is used to correct growth-hormone deficiency[7][8].
▪Schedule: Daily subcutaneous injections for 8–12 weeks, optionally extended to ~16 weeks for advanced protocols.
▪Dose Range: Conservative 150–500 mcg daily; advanced 1000–2000 mcg daily. Clinical GH-deficiency dosing is individualized to IGF-1 response.
▪Reconstitution: 3.0 mL bacteriostatic water per 10 IU (3.33 mg) vial gives ~1.11 mg/mL for accurate unit measurements.
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses.

▪Start: Begin at 200 mcg once daily and increase by ~100 mcg each week as tolerated.
▪Conservative target: 400–900 mcg daily by weeks 4–8[1].
▪Advanced target: 1000–1300 mcg daily by weeks 9–12 (performance/metabolic research)[4].
▪Frequency: Once per day subcutaneously, preferably at bedtime[2].
▪Cycle length: 8–12 weeks standard; optional extension to ~16 weeks with appropriate monitoring.
▪Timing: Evening or bedtime preferred; rotate injection sites systematically[3].

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); stable for several weeks when stored properly[5].
▪Handling: Let frozen vials reach room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution, as freezing can denature the protein.

Important Notes

Practical points that keep daily administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and prevent lipoatrophy[9].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the daily dose, injection site and any observed effects to keep the protocol consistent and track tolerance.
▪Injection only: HGH must be injected — oral dosing is ineffective because the protein is broken down in the digestive tract[6].
▪Regulatory note: Somatropin is FDA-approved for GH deficiency and certain other indications, but anti-aging, bodybuilding and body-composition uses are off-label and not approved; GH is also a WADA-prohibited substance in sport[10].
▪Real risks: GH can cause insulin resistance and raised blood glucose, fluid retention and edema, joint and muscle pain, carpal tunnel symptoms and, with excess, acromegalic changes — monitoring (including IGF-1 and glucose) is advised.

How This Works

HGH 191AA is recombinant human growth hormone (somatropin) — a 191-amino-acid protein with the same sequence as the growth hormone secreted by the pituitary gland[1][5].

GH binds growth-hormone receptors and stimulates the liver and peripheral tissues to release IGF-1, the main mediator of its growth-promoting effects. Through these pathways it promotes lipolysis (fat breakdown), increases protein synthesis and supports gains in lean body mass[7][8]. Once-daily subcutaneous dosing, often at bedtime, is designed to approximate the body’s natural overnight GH pulse[2].
Approval status: somatropin is FDA-approved — under many brand names — for genuine medical indications including pediatric and adult growth-hormone deficiency, Turner syndrome, Prader-Willi syndrome and several others[5]. Use for anti-aging, bodybuilding or body-composition is off-label and not approved for those purposes; in clinical care, dosing is individualized and titrated to IGF-1 rather than fixed.
Pivotal research by Rudman and colleagues found that six months of GH in older men increased lean body mass and reduced fat mass versus placebo[7], and long-term studies in adults with GH deficiency show sustained body-composition benefits with maintenance dosing[8]. Higher doses produce stronger effects but also real risks — insulin resistance and higher blood glucose, fluid retention and edema, joint pain and, with chronic excess, acromegalic changes.
The dosing here is drawn from reference protocols for research and educational purposes only and is not medical advice; off-label GH use should only be considered under qualified medical supervision.

Lifestyle Factors

Habits that may support body-composition and metabolic goals alongside the protocol.

▪Nutrition: Keep protein intake adequate to give lean-mass gains the building blocks they need, and watch carbohydrate quality since GH can raise blood glucose.
▪Activity & rest: Pair resistance training and appropriate movement with real recovery time.
▪Sleep: Aim for 7–9 hours; most natural GH release occurs during deep sleep.
▪Monitoring: Track fasting glucose and, where possible, IGF-1, since GH influences both.

Potential Benefits & Side Effects

What the clinical literature on somatropin describes; effects and risks are dose-dependent and individual results vary.

▪Body composition: Increased lean body mass and reduced fat mass in controlled GH studies[7].
▪Metabolic effects: Enhanced lipolysis and protein synthesis via raised IGF-1[8].
▪Established medical use: Corrects deficiency in adults and children with diagnosed GH deficiency (an FDA-approved indication).
▪Note on off-label use: Anti-aging and bodybuilding benefits are not FDA-approved and weigh against real risks.
▪Fluid retention & joints: Edema, joint and muscle pain, and carpal-tunnel symptoms are common, especially at higher doses.
▪Glucose & insulin: GH can cause insulin resistance and raise blood glucose; caution in those at risk of diabetes.
▪With excess/long term: Acromegalic changes and other endocrine effects; medical monitoring is advised. Note GH is WADA-prohibited in sport.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14][15].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each day to prevent irritation and lipoatrophy[9].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides.

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for HGH 20 IU.

HGH 191AA (10IU Vial) Dosage Protocol Open source
1 New England Journal of Medicine Rudman et al.: effects of human growth hormone on body composition in older men (lean mass, fat mass). View Source ↗ Open source
2 Journal of Clinical Endocrinology & Metabolism Physiology of pulsatile GH secretion and rationale for once-daily, bedtime subcutaneous dosing. View Source ↗ Open source
3 NCBI Bookshelf Subcutaneous injection technique and systematic site rotation to prevent lipoatrophy. View Source ↗ Open source
4 Growth Hormone & IGF Research (PubMed) Higher-dose GH in metabolic and performance research: effects and dose-dependent risks. View Source ↗ Open source
5 U.S. FDA Somatropin prescribing information: approved indications (GH deficiency, Turner, Prader-Willi) and product details. View Source ↗ Open source
6 Endocrine Reviews (PubMed) Growth hormone is a protein and must be injected; oral administration is degraded in the GI tract. View Source ↗ Open source
7 New England Journal of Medicine Rudman et al.: six months of GH increased lean body mass and decreased fat mass versus placebo. View Source ↗ Open source
8 Journal of Clinical Endocrinology & Metabolism Long-term GH replacement in adult GH deficiency: sustained body-composition and strength benefits. View Source ↗ Open source
9 NCBI Bookshelf Best practices for subcutaneous injection: aseptic technique and site rotation. View Source ↗ Open source
10 WADA Prohibited List Growth hormone (somatropin) is a prohibited substance in competitive sport. View Source ↗ Open source
11 Journal of Clinical Endocrinology & Metabolism Adverse effects of GH therapy: fluid retention, arthralgia, carpal tunnel and glucose changes. View Source ↗ Open source
12 Diabetes / Metabolism (PubMed) GH-induced insulin resistance and effects on glucose metabolism. View Source ↗ Open source
13 Peptide Storage Guide Best practices for storing lyophilized peptides and proteins (temperature, humidity, light). View Source ↗ Open source
14 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
15 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
16 Prime Lab Peptides High-purity research peptides — purity specifications and certificates of analysis. View Source ↗ Open source

Contents